| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $182.2M | — | +8.8% |
| Cost of Revenue | $88.0M | — | +13.3% |
| Gross Profit | $94.2M | — | +4.9% |
| R&D Expense | $5.2M | — | -3.7% |
| SG&A Expense | $77.7M | — | +2.6% |
| Operating Income | $8.9M | — | -13.6% |
| Pre-tax Income | $7.6M | — | -21.6% |
| Income Tax | $2.5M | — | -19.4% |
| Net Income | $5.1M | — | -22.7% |
| EPS (Basic) | $0.11 | — | -21.4% |
| EPS (Diluted) | $0.11 | — | -21.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.6M | -26.9% | -32.4% |
| Accounts Receivable | $103.0M | -0.8% | -1.7% |
| Inventory | $141.3M | -4.5% | +2.3% |
| Current Assets | $325.0M | -8.6% | -7.8% |
| Total Assets | $1.05B | -2.2% | -5.2% |
| Current Liabilities | $131.2M | -20.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.3M | — | -147.9% |
| Investing Cash Flow | -$7.7M | — | +15.4% |
| Financing Cash Flow | -$3.2M | — | +89.0% |
| -4.4% |
| Long-term Debt | $87.3M | -3.3% | -10.9% |
| Total Liabilities | $268.0M | -9.3% | -0.1% |
| Stockholders' Equity | $782.1M | +0.5% | -6.8% |